9月3日 - ** Sotera HealthSHC.O启动二次发行，盘后股价下跌5.4%，至15.11美元
** 总部位于俄亥俄州的消毒和实验室设备测试服务公司称， (link)，私募股权投资公司华平投资和GTCR将分道扬镳，减持2000万股。
** 根据招股说明书，发行前，华平持有 7,380 万股，约占 26% 的股份，GTCR 持有 4,920 万股，约占 SHC 约 2.84 亿流通股的 17.33 (link)
** 高盛是此次发行的唯一承销商
** SHC 股票周三常规交易时段收盘下跌 1.1%，报 15.98 美元
** 股价在过去一个月上涨了约 42%，今年累计上涨了约 17
** 7 位分析师中有 4 位将该股评为 "强力买入 "或 "买入"，其余评为 "持有"，PT 中值为 17 美元，LSEG 数据反映了这一点
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.